A new potential treatment strategy against childhood cancer with high mortality

Neuroblastoma is a cancer in children that originates in the sympathetic nervous system and has a high mortality. Current treatment includes chemotherapy and radiotherapy with their potentially severe side effects; there is therefore an urgent need for a new improved drug.

One potential treatment strategy is to use a drug to target deviant molecular signalling caused by changes in genes.

Cecilia Dyberg is a researcher at the Department of Women's and Children's Health and first author of a study which will be published in the journal PNAS.